Cost of Adverse Events Related to How Often Follow-Up Occurs Among Patients With Cancer That Has Spread
| Status: | Completed |
|---|---|
| Conditions: | Skin Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/7/2017 |
| Start Date: | February 27, 2017 |
| End Date: | September 30, 2017 |
Economic Burden of Adverse Events Associated With Follow-Up Frequency Among Patients With Metastatic Melanoma
This study is a real-world retrospective claims analysis to assess and compare AE-related
HCRU and medical costs among patients with different follow-up frequency after initiating a
melanoma therapy.
HCRU and medical costs among patients with different follow-up frequency after initiating a
melanoma therapy.
Inclusion Criteria:
- Diagnosed with metastatic melanoma
- Initiated at least 1 treatment for metastatic melanoma after 2011
- Continuous enrollment in their healthcare plan for at least 6 months before and at
least 6 weeks after the index date
- Patients who received at least 1 dose of study drug in CA209-067
We found this trial at
1
site
Click here to add this to my saved trials
